Genetics of Pulmonary Fibrosis

R. M. du Bois; I. Kangesan; S. Veeraraghavan

doi:10.1055/s-2003-39019

Seminars in Respiratory and Critical Care Medicine, Table of Contents

Semin Respir Crit Care Med 2003; 24(2): 205-212
DOI: 10.1055/s-2003-39019

Genetics of Pulmonary Fibrosis

R. M. du Bois, I. Kangesan, S. Veeraraghavan

Interstitial Lung Disease Unit and Clinical Genomics Group, Royal Brompton Hospital, London, United Kingdom

Abstract

ABSTRACT

Identifying genetic determinants of pulmonary fibrosis is at an early stage of evolution. It is now well recognized that "pulmonary fibrosis" covers a broad range of lung diseases including most topically the idiopathic interstitial pneumonias that have been classified recently. Additionally, it is recognized that the diffuse lung diseases of children that may progress to fibrosis are quite different from those of adults. Defining clinical phenotype is an absolute prerequisite to precise identification of genetic determinants, and this is at least part of the reason why we understand relatively little of these genetic determinants to date.

In children, a number of mutations have been identified, particularly with regard to surfactant protein. In adults, families with idiopathic pulmonary fibrosis are being collected but there are no genetic data on these at this point. In sporadic disease, associations have been reported in early phase genes with disease predisposition and also, importantly, with disease severity: future studies will inevitably incorporate issues of severity of disease in analyses.

KEYWORDS

Genetics - diffuse lung disease - idiopathic pulmonary fibrosis

Full Text

References

REFERENCES

1 American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med . 2002; 165 277-304
2 Wright J A, Pennington J E. Familial lymphoid interstitial pneumonitis. J Pediatr . 1987; 111 638
3 Buchino J J, Keenan W J, Algren J T, Bove K E. Familial desquamative interstitial pneumonitis occurring in infants. Am J Med Genet Suppl . 1987; 3 285-291
4 Tal A, Maor E, Bar-Ziv J, Gorodischer R. Fatal desquamative interstitial pneumonia in three infants siblings. J Pediatr . 1984; 104 873-876
5 Canakis A M, Cutz E, Manson D, O'Brodovich H. Pulmonary interstitial glycogenosis: a new variant of neonatal interstitial lung disease. Am J Respir Crit Care Med . 2002; 165 1557-1565
6 Fan L L, Langston C. Pediatric interstitial lung disease: children are not small adults. Am J Respir Crit Care Med . 2002; 165 1466-1467
7 Low R B. Bronchoalveolar lavage lipids in idiopathic pulmonary fibrosis. Chest . 1989; 95 3-5
8 Wilsher M L, Hughes D A, Haslam P L. Immunoregulatory properties of pulmonary surfactant: influence of variations in the phospholipid profile. Clin Exp Immunol . 1988; 73 117-122
9 Hughes D A, Haslam P L. Changes in phosphatidylglycerol in bronchoalveolar lavage fluids from patients with cryptogenic fibrosing alveolitis. Chest . 1989; 95 82-89
10 Amin R S, Wert S E, Baughman R P. et al . Surfactant protein deficiency in familial interstitial lung disease. J Pediatr . 2001; 139 85-92
11 Karinch A M, deMello D E, Floros J. Effect of genotype on the levels of surfactant protein A mRNA and on the SP-A2 splice variants in adult humans. Biochem J . 1997; 321(pt 1) 39-47
12 Diangelo S, Lin Z, Wang G. et al . Novel, nonradioactive, simple and multiplex PCR-cRFLP methods for genotyping human SP-A and SP-D marker alleles. Dis Markers . 1999; 15 269-281
13 Lin Z, deMello D E, Batanian J R. et al . Aberrant SP-B mRNA in lung tissue of patients with congenital alveolar proteinosis (CAP). Clin Genet . 2000; 57 359-369
14 Floros J, Veletza S V, Kotikalapudi P. et al . Dinucleotide repeats in the human surfactant protein-B gene and respiratory-distress syndrome. Biochem J . 1995; 305(pt 2) 583-590
15 Lin Z, deMello D E, Wallot M, Floros J. An SP-B gene mutation responsible for SP-B deficiency in fatal congenital alveolar proteinosis: evidence for a mutation hotspot in exon 4. Mol Genet Metab . 1998; 64 25-35
16 Nogee L M, Wert S E, Proffit S A, Hull W M, Whitsett J A. Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency. Am J Respir Crit Care Med . 2000; 161(3 pt 1) 973-981
17 Nogee L M, Dunbar III E A, Wert S E, Askin F, Hamvas A, Whitsett J A. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med . 2001; 344 573-579
18 Glasser S W, Korfhagen T R, Perme C M, Pilot-Matias T J, Kister S E, Whitsett J A. Two SP-C genes encoding human pulmonary surfactant proteolipid. J Biol Chem . 1988; 263 10326-10331
19 Nogee L M, Dunbar III E A, Wert S E, Askin F, Hamvas A, Whitsett J A. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med . 2001; 344 573-579
20 Nogee L M, Dunbar III E A, Wert S, Askin F, Hamvas A, Whitsett J A. Mutations in the surfactant protein C gene associated with interstitial lung disease. Chest . 2002; 121(suppl 3) S20-S21
21 Marshall R P, Puddicombe A, Cookson W O, Laurent G J. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax . 2000; 55 143-146
22 Bitterman P B, Rennard S I, Keogh B A. Familial idiopathic pulmonary fibrosis: evidence of lung inflammation in unaffected family members. N Engl J Med . 1986; 314 1343-1347
23 Peabody J W, Peabody Jr W J, Hayes E W, Hayes Jr W E. Idiopathic pulmonary fibrosis: its occurrence in identical twin sisters. Dis Chest . 1950; 18 330-344
24 Bonanni P P, Frymoyer J W, Jacox R F. A family study of idiopathic pulmonary fibrosis: a possible dysproteinemic and genetically determined disease. Am J Med . 1965; 39 411-421
25 Marney A, Lane K B, Phillips III A J, Riley D J, Loyd J E. Idiopathic pulmonary fibrosis can be an autosomal dominant trait in some families. Chest . 2001; 120(suppl 1) S30
26 Wahidi M M, Speer M C, Steele M P, Brown K K, Schwarz M I, Schwartz D A. Familial pulmonary fibrosis in the United States. Chest . 2002; 121(suppl 3) S30
27 Hodgson U, Laitinen T, Tukiainen P. Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax . 2002; 57 338-342
28 Thomas A Q, Lane K, Phillips III J. et al . Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med . 2002; 165 1322-1328
29 Brantly M, Avila N A, Shotelersuk V, Lucero C, Huizing M, Gahl W A. Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1. Chest . 2000; 117 129-136
30 Gahl W A, Brantly M, Kaiser-Kupfer M I. et al . Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome). N Engl J Med . 1998; 338 1258-1264
31 Huizing M, Gahl W A. Disorders of vesicles of lysosomal lineage: the Hermansky-Pudlak syndromes. Curr Mol Med . 2002; 2 451-467
32 Vassilakis D A, Sourvinos G, Spandidos D A, Siafakas N M, Bouros D. Frequent genetic alterations at the microsatellite level in cytologic sputum samples of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med . 2000; 162(3 pt 1) 1115-1119
33 Mori M, Kida H, Morishita H. et al . Microsatellite instability in transforming growth factor-beta 1 type II receptor gene in alveolar lining epithelial cells of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol . 2001; 24 398-404
34 Kunitake R, Kuwano K, Miyazaki H. et al . Expression of p53, p21 (Waf1/Cip1/Sdi1) and Fas antigen in collagen vascular and granulomatous lung diseases. Eur Respir J . 1998; 12 920-925
35 Hojo S, Fujita J, Yamadori I. et al . Heterogeneous point mutations of the p53 gene in pulmonary fibrosis. Eur Respir J . 1998; 12 1404-1408
36 Whyte M, Hubbard R, Meliconi R. et al . Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms. Am J Respir Crit Care Med . 2000; 162(2 pt 1) 755-758
37 Hutyrova B, Pantelidis P, Drabek J. et al . Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med . 2002; 165 148-151
38 Pantelidis P, Fanning G C, Wells A U, Welsh K I, du Bois M R. Analysis of tumor necrosis factor-alpha, lymphotoxin-alpha, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med . 2001; 163 1432-1436
39 Bouros D, Wells A U, Nicholson A G. et al . Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med . 2002; 165 1581-1586
40 Gilchrist F C, Bunn C, Foley P J. et al . Class II HLA associations with autoantibodies in scleroderma: a highly significant role for HLA-DP. Genes Immun . 2001; 2 76-81
41 Arnett F C. HLA and autoimmunity in scleroderma (systemic sclerosis) [review]. Int Rev Immunol . 1995; 12 107-128
42 Kuwana M, Medsger Jr A T, Wright T M. T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors. J Clin Invest . 1995; 96 586-596
43 Avila J J, Lympany P A, Pantelidis P, Welsh K I, Black C M, du Bois M R. Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis. Am J Respir Cell Mol Biol . 1999; 20 106-112
44 Renzoni E, Lympany P, Sestini P. et al . Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthritis Rheum . 2000; 43 1633-1640